This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Harold L. Klawans, MD; Christopher Goetz; Donna Bergen, MD

Arch Neurol. 1975;32(5):331-334.

Abstract
Twelve parkinsonian patients on long-term levodopa therapy developed intermittent, myoclonic body jerks. The movements consisted of single unilateral or bilateral abrupt jerks of the extremities and occurred most frequently during sleep. Although directly related to daily dosage of levodopa, the myoclonus was specifically blocked by the serotonin antagonist, methysergide. Levodopa-induced myoclonus may be related to intermittent increases of activity of serotonin in the brain and results from levodopa-induced dysregulation of serotonin activity.

Author Affiliations
From the Division of Neurology, Michael Reese Medical Center, and University of Chicago, Pritzker School of Medicine (Dr. Klawans); Rush Medical College (Dr. Goetz); and Department of Neurology, Rush-Presbyterian-St. Luke's Medical Center (Dr. Bergen), Chicago.

Footnotes
Accepted for publication Aug 13, 1974.

Reprint requests to Division of Neurology, Michael Reese Medical Center, 2929 S Ellis, Chicago, IL 60616 (Dr. Klawans).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serotonin and Human Myoclonus: Rationale for the Use of Serotonin Receptor Agonists and Antagonists
Pranzatelli
Arch Neurol 1994;51:605-617.
ABSTRACT  

Neurology
Dalessio
JAMA 1981;245:2200-2202.
ABSTRACT